• 29 Hits
  • Search Condition : Filter (MeSH = Lung Neoplasms / enzymology)
Species Resource Title
Human and Animal Cells SQ-5(RCB0110) Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay.
Human and Animal Cells B16 , B16F10(RCB2630) The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cells.
Human and Animal Cells LC-2/ad(RCB0440) HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Human and Animal Cells A549 , LC-ARERF-LC-AI(RCB0444) The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
Human and Animal Cells PC-9(RCB4455) DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.
Human and Animal Cells LC-2/ad(RCB0440) Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma.
Human and Animal Cells KP4(RCB1005) Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.
Human and Animal Cells Lu-134-B(RCB0467) , Lu-135(RCB0468) , Lu-139(RCB0469) , Lu-140(RCB0470) Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cells.
Human and Animal Cells PC-9(RCB4455) Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
Human and Animal Cells Lu99(RCB1900) Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
Human and Animal Cells PMF-ko14(RCB1426) The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.
Human and Animal Cells Ba/F3(RCB0805) , PC-9(RCB4455) TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations.
Human and Animal Cells Ba/F3 Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Human and Animal Cells 293(RCB1637) Identification of ryuvidine as a KDM5A inhibitor.
Human and Animal Cells MRC-5(RCB0211) Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status.
Drosophila Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling.
Human and Animal Cells MRC-5 Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitors.
Human and Animal Cells LLC(RCB0558) Expression of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase involved in chondroitin sulfate synthesis is responsible for pulmonary metastasis.
Human and Animal Cells HCE-T(RCB2280) Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activities.
Human and Animal Cells A549(RCB0098) Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells.